EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

THE IMPACT OF ANTIDIABETES AGENTS IN COVID-19 PATIENT

Antonio Vitiello, Raffaele La Porta, Chiara Pelliccia, Francesco Ferrara*

ABSTRACT

Beckgroung:The current Covid 19 infection has been one of the most difficult challenges the world has faced in recent years, mainly due to fatal lung injury caused by a generalized inflammatory state. Objective: Diabetes patients are those most at risk of contracting Covid infection19. Materials and method: the main risk factors are age, concomitant drug therapy, kidney failure, hyperglycaemia, and copresence of cardiovascular disease. Regulating the blood glucose level is important. Results: the patient with diabetes must be monitored both in the pharmacological treatment in case of infection and in the preventive phase in the regulation of glycaemia. Conclusion: this article is intended to check the clinical condition of a diabetic patient with Covid19.

Keywords: COVID-19, inflammatory, diabetes, hyperglycemia, immunomodulants, Sars-Cov-2.

[Full Text Article] [Download Certificate]